Logged in as: Guest
WCN'24 Home
View detailed Congress Program
View Program at a glance
LOGIN
ORIGIN 3: PIVOTAL PHASE 3 STUDY EVALUATING EFFECT OF ATACICEPT VS PLACEBO ON PROTEINURIA AND RENAL FUNCTION PRESERVATION IN IGA NEPHROPATHY
Back
E-Poster
https://storage.unitedwebnetwork.com/files/1099/bde6e3b5230fa2440eabd951de583806.pdf
Abstract Title
ORIGIN 3: PIVOTAL PHASE 3 STUDY EVALUATING EFFECT OF ATACICEPT VS PLACEBO ON PROTEINURIA AND RENAL FUNCTION PRESERVATION IN IGA NEPHROPATHY
First Name *
Jonathan
Last Name *
Barratt
Co-author 1
Bart Maes bart.maes@azdelta.be AZ Delta Nephrology Roeselare
Co-author 2
Rubeen Israni rubeen.israni@veratx.com Vera Therapeutics Clinical Development Brisbane
Co-author 3
Xuelian Wei xuelian.wei@veratx.com Vera Therapeutics Biostatistics Brisbane
Co-author 4
Jürgen Floege jfloege@ukaachen.de RWTH Aachen University Nephrology Aachen
Co-author 5
Vivekanand Jha vjha@georgeinstitute.org.in The George Institute for Global Health India Nephrology New Delhi
Co-author 6
Vladimir Tesar vladimir.tesar@vfn.cz Charles University Nephrology Prague
Co-author 7
Hong Zhang hongzh@bjmu.edu.cn Peking University First Hospital Renal Beijing
Co-author 8
Sean Barbour sean.barbour@vch.ca University of British Columbia Nephrology Vancouver
Co-author 9
Hitoshi Suzuki shitoshi@juntendo.ac.jp Juntendo University Faculty of Medicine Nephrology Tokyo
Co-author 10
Hernan Trimarchi htrimarchi@hotmail.com Hospital Británico de Buenos Aires Nephrology Buenos Aires
Co-author 11
Celia Lin celia.lin@veratx.com Vera Therapeutics Medical Brisbane
Co-author 12
Richard Lafayette czar@stanford.edu Stanford University Nephrology Stanford
Co-author 13
Co-author 14
Co-author 15
